Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days

NCT00237445 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia

Interventions

DRUG: telithromycin
DRUG: azithromycin

Sponsor

Sanofi